Esbl virus wiki

It's also a good idea to know your test results and keep a list of the medicines you take. Author: Healthwise Staff. Medical Review: E. Russo MD - Internal Medicine. Care instructions adapted under license by your healthcare professional. If you have questions about a medical condition or this instruction, always ask your healthcare professional. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again. Important Phone Numbers.

What are the symptoms? How is an ESBL infection treated? How can you prevent the spread of an ESBL infection? Where can you learn more? Top of the page. What is an ESBL infection? For example: If the infection is in the skin, that area may be red or tender.

If it's in the urinary tract, you may have back pain, a burning sensation when you urinate, or a need to urinate more often than usual. Centers for Disease Control and Prevention www. Your feedback will help us improve the information we provide to patients and caregivers. We read every comment, but we're not able to respond. If you have questions about your care, contact your healthcare provider. For more resources, visit www. Skip to main content Important Update to Visitor Policy. Back to top What is extended spectrum beta-lactamase?

ESBL infections occur more often in people who: Are older Have weakened immune systems Have chronic illnesses, such as cancer and diabetes Have been treated with antibiotics in the past Had a recent surgery Have had repeated or long hospital stays Have open wounds or sores Have tubes or drains in their body Back to top What are the symptoms of an ESBL infection? The symptoms vary depending on the location and type of infection.

A sign will be posted on the door instructing all staff to clean their hands with soap and water or an alcohol-based hand sanitizer before going into and after leaving your room. All staff will need to wear a yellow gown and gloves while in your room.

There are still a few antibiotics that can be used to treat infections caused by ESBL-producing bacteria. However, current antibiotics will continue to become less effective unless used only when really needed. It is also very important to use antibiotics in the correct dose for the full recommended course of treatment. Therefore, the remainder of this leaflet refers to E. There are many strains subtypes of E. Many of the strains of E.

However, some strains are a cause of common infections such as urine infections and gut infections gastroenteritis. For example, cystitis , kidney infections and other ' urine infections '. These are the most common infections caused by E. About 9 in 10 UTIs are caused by strains of E. Many of the strains are those which live harmlessly in the gut but can cause a UTI if they get into the bladder or other parts of the urinary tract.

This is commonly due to various strains which do not normally live in the gut. Gastroenteritis can cause symptoms of runny stools diarrhoea , being sick vomiting , high temperature fever and tummy abdominal pain. The source of the infecting strains is often from contaminated food 'food poisoning' or from other people who have the infection. Traveller's diarrhoea is often caused by a strain of E.

The E. These are infections that occur inside the abdomen, often when a part of the gut is damaged or punctured perforated. Lagrange, and A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

Sanson-le Pors, M. Rouveau, G. Fournier, O. Marie, B. Schlemmer, and A. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Asensio, A. Oliver, P. Gonzalez-Diego, F. Baquero, J. Perez-Diaz, P. Ros, J. Cobo, M. Palacios, D. Lasheras, and R. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection.

Babini, G. Antimicrobial resistance amongst Klebsiella spp. Are SHV beta-lactamases universal in Klebsiella pneumoniae? Baraniak, A. Fiett, W. Hryniewicz, P. Nordmann, and M. Fiett, A. Sulikowska, W. Hryniewicz, and M. Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Sadowy, W. Barguellil, F. Burucoa, A. Amor, J. Fauchere, and C. In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy.

Bauernfeind, A. Casellas, M. Goldberg, M. Holley, R. Jungwirth, P. Mangold, T. Rohnisch, S. Schweighart, and R. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20 : Rosenthal, E. Eberlein, M. Holley, and S. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 21 : Stemplinger, R. Jungwirth, S. Ernst, and J.

Mangold, S. Amann, E. Akalin, O. Ang, C. Bal, and J. Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Bedenic, B. Beader, and Z. Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases.

Randegger, A. Boras, and H. Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases. Randegger, E. Stobberingh, and H. Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Bell, J. Turnidge, A. Gales, M. Pfaller, and R. Bellais, S. Poirel, N. Fortineau, J.

Decousser, and P. Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.

Ben Redjeb, S. Ben Yaghlane, A. Boujnah, A. Philippon, and R. Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae , Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. Fournier, C. Mabilat, A. Ben Hassen, and A. Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol. Bermudes, H. Arpin, F. Jude, Z.

Bebear, and C. Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital. Bingen, E. Desjardins, G. Arlet, F. Bourgeois, P. Mariani-Kurkdjian, N. Lambert-Zechovsky, E. Denamur, A. Philippon, and J. Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. Bird, J. Browning, R. Hobson, F. MacKenzie, J. Brand, and I. Multiply-resistant Klebsiella pneumoniae : failure of spread in community-based elderly care facilities.

Bisson, G. Fishman, J. Patel, P. Edelstein, and E. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Blahova, J. Kralikova, V. Krcmery, Sr. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.

Blomberg, B. Jureen, K. Manji, B. Tamim, D. Mwakagile, W. Urassa, M. Fataki, V. Msangi, M. Tellevik, S. Maselle, and N. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. Bonnet, R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Dutour, J. Sampaio, C. Chanal, D. Sirot, R. Labia, C. De Champs, and J. Sirot, C. De Champs, J. Viallard, R. Labia, and J. Sampaio, R. De Champs, D. Chanal, and J. Borer, A. Gilad, G. Menashe, N. Peled, K. Riesenberg, and F. Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in southern Israel. Bosi, C. Davin-Regli, C. Bornet, M. Mallea, J. Pages, and C. Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Bou, G. Cartelle, M. Tomas, D. Canle, F. Molina, R. Moure, J. Eiros, and A. Identification and broad dissemination of the CTX-M beta-lactamase in different Escherichia coli strains in the northwest area of Spain. Boyd, D. Tyler, S. Christianson, A. McGeer, M. Muller, B. Willey, E. Bryce, M. Gardam, P. Complete nucleotide sequence of a kilobase plasmid harboring the CTX-M extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Bradford, P. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. Rahal, S. Brooks, S. Cebular, and J. Cherubin, V. Idemyor, B. Rasmussen, and K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM and TEM ceftazidime-hydrolyzing beta-lactamases in a single isolate. Urban, A. Jaiswal, N.

Mariano, B. Rasmussen, S. Projan, J. Rahal, and K. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Mariano, S. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Yang, D.

Sahm, I. Grope, D. Gardovska, and G. CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia. Branger, C. Bruneau, A. Lesimple, P. Berry, J. Sevali-Garcia, and N. Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. Brenwald, N.

Jevons, J. Andrews, J. Xiong, P. Hawkey, and R. An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae : the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.

Brigante, G. Luzzaro, M. Perilli, G. Lombardi, A. Coli, G. Rossolini, G. Amicosante, and A. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. Agents 25 : Brisse, S. Milatovic, A. Fluit, J. Verhoef, and F. Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Brown, D.

Andrews, A. King, and A. Detection of extended-spectrum beta-lactamases with Etest and double-disc potentiation methods. Brun-Buisson, C. Legrand, A. Philippon, F. Montravers, M. Ansquer, and J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Lancet ii : Rauss, C. Richard, F. Besbes, J. Meakins, C. Soussy, and F. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Bureau-Chalot, F. Drieux, C. Pierrat-Solans, D. Forte, C. Blood pressure cuffs as potential reservoirs of extended-spectrum beta-lactamase VEBproducing isolates of Acinetobacter baumannii.

Burgess, D. Hall, Jr.